India's Jubilant Pharmova soars to 3 yr-high on upbeat Q1 results
** Shares of Indian drugmaker Jubilant Pharmova JUBA.NS
rise as much as 10%, highest levels since June 2021
** Co last up 3.1%
** Co's consol Q1 adjusted profit nearly quadrupled y/y, rev
rose 9%
** Trading vols ~8x 30-day avg
** YTD stock has gained ~42%
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures